Literature DB >> 11173611

M-ESLON(R) (retard release morphine sulphate capsules) for Pain Control in Cancer Patients.

Attila J Horváth1, Anita Szabó, Tünde Gáspár, Lajos Bognár, Miklós Tekeres.   

Abstract

The pain of patients who were in the terminal phase of advanced malignant tumors was successfully relieved by M-ESLON(R) capsules of controlled release morphine sulphate (10 30 60 100 mg). The most frequent side effects (sickness, vomiting, obstipation) were effectively controlled. The concentration of the drug in the plasma was stable, therefore the lasting pain relief was ensured.

Entities:  

Year:  1996        PMID: 11173611     DOI: 10.1007/bf02904818

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  4 in total

Review 1.  Oral morphine in chronic cancer pain.

Authors:  T D Walsh
Journal:  Pain       Date:  1984-01       Impact factor: 6.961

Review 2.  The treatment of cancer pain.

Authors:  K M Foley
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

3.  The prevalence and severity of pain in cancer.

Authors:  R L Daut; C S Cleeland
Journal:  Cancer       Date:  1982-11-01       Impact factor: 6.860

4.  Pain in far-advanced cancer.

Authors:  Robert G Twycross; Sarah Fairfield
Journal:  Pain       Date:  1982-11       Impact factor: 6.961

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.